Data from patients with hepatocellular carcinoma (HCC), HBV-positive patients with HCC, and patients negative for both HBV and HCC also suggest that HBV-induced m6A-methylation of PTEN might be responsible for HCC development via disruption of the PI3K pathway (Figure 8) [126]. This evidence concerns the gene PTEN and hepatocellular carcinoma.